Congenital hypothyroidism and thyroid cancer

Area of Science:

• Endocrinology
• Pediatric Oncology
• Molecular Biology

Background:

• Congenital hypothyroidism (CH) is a common endocrine disorder.
• Differentiated thyroid carcinoma (DTC) in childhood is rare (0.4-3% of pediatric malignancies).
• The co-occurrence of CH and DTC is infrequent, with potential links to dyshormonogenetic goiter or developmental issues.

Purpose of the Study:

• To explore clinical features and molecular mechanisms linking CH and DTC.
• To propose an analytical framework for understanding the CH-DTC relationship.
• To highlight diagnostic challenges in CH patients with nodular goiter.

Main Methods:

• Literature review focusing on clinical and molecular aspects.
• Analysis of potential molecular mechanisms including gene mutations and hormonal influences.
• Discussion of diagnostic pitfalls in CH with nodular goiter.

Main Results:

• Potential mechanisms include sporadic somatic mutations, elevated TSH, increased H2O2, and mutations in genes like Borealin/CDC8.
• Dyshormonogenesis and CH-related genetic factors may contribute to DTC.
• Diagnostic challenges exist due to altered nodule appearance in CH patients.

Conclusions:

• The interplay of genetic, epigenetic, and signaling pathways in CH may promote DTC.
• Further research is needed to elucidate the exact mechanisms of thyroid cancer development in CH.
• A comprehensive framework is proposed to understand the CH-DTC association.